Week In Review: WuXi PharmaTech Pays $65 Million For Genomics Company

WuXi PharmaTech, the China-US CRO/CMO, paid $65 million in cash to acquire NextCODE Health, a genomic analysis and bioinformatics company with operations in the US and Iceland.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.